Macao vs Switzerland: The number of people with susceptibility test result for rifampicin
Macao
193
in 2021
Switzerland
220
in 2021
Macao rank
95th
Switzerland rank
92nd
The number of people with susceptibility test result for rifampicin over time
- Macao
- Switzerland
How they compare
Switzerland currently reports 220 against 193 in Macao, a difference of 27.
That makes Switzerland's figure about 1.1 times Macao's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Switzerland ahead.
Macao ranks 95th and Switzerland ranks 92nd of 155 countries.
Across the 2 decades both report, Macao averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Macao | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.33 | 240.33 | 20 | Switzerland |
| 2020s | 201 | 195.5 | 5.5 | Macao |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Macao or Switzerland?
- Switzerland, at 220 against 193 in Macao as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Macao and Switzerland?
- 27, with Switzerland ahead.
- How many years of comparable data are there for Macao and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Macao and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Macao ranks 95th and Switzerland ranks 92nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.